Idiopathic intracranial hypertension: Associations with thrombophilia and hypofibrinolysis in men

Clinical and Applied Thrombosis/Hemostasis

Volumn 11, Issue 4, 2005, Pages 441-448

  Glueck, Charles J ^a,c   Goldenberg, Naila ^a   Golnik, Karl ^b   Sieve, Luann ^a   Wang, Ping ^a  

^a JEWISH HOSPITAL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Cholesterol Center   (United States)

Author keywords

Hypofibrinolysis; Idiopathic intracranial hypertension; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTITHROMBIN III; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; FIBRINOGEN RECEPTOR; GENE PRODUCT; HOMOCYSTEINE; LIPOPROTEIN A; LUPUS ANTICOAGULANT; PLASMINOGEN ACTIVATOR INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; PROTHROMBIN; VIPER VENOM;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AFRICAN AMERICAN; ARACHNOID; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; BODY MASS; CAUCASIAN; CEREBROSPINAL FLUID FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; GENE MUTATION; HERITABILITY; HOMOZYGOSITY; HUMAN; HYPOFIBRINOLYSIS; INTRACRANIAL HYPERTENSION; MALE; MICROTHROMBUS; OBESITY; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; RUSSEL VIPER VENOM TIME; SCHOOL CHILD; THROMBOPHILIA;

ADOLESCENT; ADULT; BLOOD COAGULATION; BODY MASS INDEX; CHILD; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PSEUDOTUMOR CEREBRI; SEX CHARACTERISTICS; THROMBOPHILIA;

EID: 14544278192     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960501100411     Document Type: Article

References (54)

1. Binder DK, Horton JC, Lawton MT, et al. Idiopathic intracranial hypertension. Neurosurgery 2004;54:538.
2. Brazis PW, Lee AG. Elevated intracranial pressure and pseudotumor cerebri. Curr Opin Ophthalmol 1998;9:27.
3. Kesler A, Goldhammer Y, Gadoth N. Do men with pseudomotor cerebri share the same characteristics as women? A retrospective review of 141 cases. J Neuroophthalmol 2001;21:15.
4. Bandyopadhyay S. Pseudotumor cerebri. Arch Neurol 2001;58:1699.
5. Kesler A, Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 2001;21:12.
6. Duncan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988;45:875.
7. Kesler A, Gadoth N. Pseudotumor cerebri (PTC-an update). Harefuah 2002;141:297.
8. Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988;45:866.
9. Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in a pediatric population. J Child Neurol 2002;17:745.
10. Glueck CJ, Iyengar S, Goldenberg N, et al. Idiopathic intracranial hypertension. Associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med 2003;142:35.
11. Glueck CJ, Goldenberg N, Golnik K, et al. Idiopathic intracranial hypertension: Associations with coagulation disorders and polycystic ovary syndrome. J Invest Med 2004;52(suppl 2):S 382, Abstract.
12. Glueck CJ, Bell H, Wang P, et al. Idiopathic intracranial hypertension: Associations with coagulation disorders in men. J Invest Med 2004;52(suppl 2):S 349, Abstract.
13. Sussman J, Leach M, Greaves M, et al. Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1997;62:229.
14. Daif A, Awada A, al-Rajeh S, et al. Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke 1995;26:1193.
15. Dunkley S, Johnston I. Thrombophilia as a common pre-disposing factor in pseudotumor cerebri. Blood 2004;103:1972.
16. Munts AG, Vangenderen PJ, Dippel DW, et al. Coagulation disorders in young adults with acute cerebral ischaemia. J Neural 1998;245:21.
17. de Bruijn SF, Stam J, Koopman MM, et al. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ 1998;316:589.
18. Singh K, Chye GC. Adverse effects associated with contraceptive implants: Incidence, prevention and management. Adv Contracept 1998;14:1.
19. Wysowski DK, Green L. Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch spontaneous reporting system. Obstet Gynecol 1995;85:538.
20. Meyer-Heim A, Landau K, Boltshauser E. Treatment of acne with consequences-pseudotumor cerebri due to hypervitaminosis A. Schweiz Rundsch Med Prax 2002;91:23.
21. Somech R, Arav-Boger R, Assia A, et al. Complications of minocycline therapy for acne vulgaris: Case reports and review of the literature. Pediatr Dermatol 1999;16:469.
22. Rogers AH, Rogers GL, Bremer DL, et al. Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology 1999;106:1186.
23. Green L, Vinker S, Amital H, et al. Pseudotumor cerebri in systemic lupus erythematosus. Semin Arthritis Rheum 1995;25:103.
24. Sylaja PN, Moosa A, Radhakrishnan K, et al. Differential diagnosis of patients with intracranial sinus venous thrombosis related isolated intracranial hypertension from those with idiopathic intracranial hypertension. J Neurol Sci 2003;215:9.
25. Balasa W, Gruppo R, Glueck CJ, et al. The relationship of mutations in the methylenetetrahydrofolate reductase, prothrombin, and plasminogen activator inhibitor-1 genes to plasma levels of homocysteine, prothrombin, and plasminogen activator inhibitor-1 levels in children and adults. Thromb Haemost 1999;81:739.
26. Glueck CJ, Fontaine RN, Wang P. Interaction of heritable and estrogen-induced thrombophilia: Possible pathoetiologies for ischemic optic neuropathy and ischemic stroke. Thromb Haemost 2001;85:256.
27. Glueck CJ, Freiberg RA, Fontaine RN, et al. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop 2002;386:19.
28. Glueck CJ, Bell H, Vadlamani L, et al. Heritable thrombophilia and hypofibrinolysis. Arch Ophthalmol 1999;117:43.
29. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: An update. Thromb Haemost 1995;74:1185.
30. SAS Release 8. 2002. SAS institute, SAS Circle, Box 8000, Gary NC 27512-8000.
31. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723.
32. O'Donnell J, Tuddenham EG, Manning R, et al. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: Role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1997;77:825.
33. Glueck CJ, Wang P, Sieve-Smith L, et al. Metformin induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with polycystic ovary syndrome. Metabolism 1999;48:511.
34. Hoibraaten E, Mowinckel MC, de Ronde H, et al. Hormone replacement therapy and acquired resistance to activated protein C: Results of a randomized, double-blind, placebo-controlled trial. Br J Haematol 2001;115:415.
35. Hoibraaten E, Qvigstad E, Anderson TO, et al. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism-results from a randomized, double-blind, clinical trial. Thromb Haemost 2001;85:775.
36. Glueck CJ, Kupfermine MJ, Fontaine RN, et al. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001;97:44.
37. Sugerman HJ, DeMaria EJ, Felton WL 3rd, et al. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 1997;49:507.
38. Karahalios DG, Rekate HL, Khayata MH, et al. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996;46:198.
39. O'Donnell J, Mumford AD, Manning RA, et al. Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 2002;83:10.
40. Kraaijenhagen RA, in't Anker PS, Koopman MM, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000;83:5.
41. O'Donnell J, Laffan M. Elevated plasma factor VIII levels-a novel risk factor for venous thromboembolism. Clin Lab 2001;47:1.
42. Benilde CL, Michela C, Mirella F, et al. High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. Br J Haematol 2004;124:504.
43. Kamphuisen PW, Houwing-Duistermaat JJ, van Houwelingen HC, et al. Familial clustering of factor VIII and von Willebrand factor levels. Thromb Haemost 1998;79:323.
44. Kamphuisen PW, Lensen R, Houwing-Duistermaat JJ, et al. Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. Br J Haematol 2000;109:519.
45. Schambeck CM, Hinney K, Haubitz I, et al. Familial clustering of high factor VIII levels in patients with venous thromboembolism. Arterioscler Thromb Vasc Biol 2001;21:289.
46. Capucci G, Margaglione M, Ames PR. Comparative prevalence of antiphospholipid antibodies and thrombophilic genotypes in consecutive patients with venous thrombosis. Blood Coagul Fibrinolysis 2001;12:659.
47. Field SL, Brighton TA, McNeil HP, et al. Recent insights into antiphospholipid antibody-mediated thrombosis. Ballieres Best Pract Res Clin Haematol 1999;12:407.
48. Meroni PL, Moia M, Derksen RH, et al. Venous thromboembolism in the antiphospholipid syndrome: Management guidelines for secondary prophylaxis. Lupus 2003;12:504.
49. Juhan-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med 2000;32(suppl 1):78.
50. Huber K. Plasminogen activator inhibitor type-1 (part one); basic mechanisms, regulation, and role for thromboembolic disease. J Thromb Thromb 2001;11:183.
51. Tassies D, Espinosa G, Munoz-Rodriguez FJ, et al. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthri Rheum 2000;43:2349.
52. Sartori MT, Wiman B, Vettore S, et al. 4G/5G polymorphism of PAI-1 promoter and fibrinolytic capacity in patients with deep vein thrombosis. Thromb Haemost 1998;80:956.
53. Glueck CJ, Wang P, Bornovali S, et al. Polycystic ovary syndrome, the G1691A factor V Leiden mutation, and plasminogen activator inhibitor activity: Associations with recurrent pregnancy loss. Metabolism 2003;52:1627.
54. Golnik K, Kardon R, Wall M, et al. Sleep apnea and intracranial hypertension in men. Ophthalmology 2002;109:482.